We help you to sell your pharma business in Germany. Our local M&A advisors know the pharma industry in Germany well. The advisors of CFIE have access to international and local buyers. We bring you suited pharma investors that can help in investing and growing your business for sale. Our European pharmaceutical M&A advisors have access to a large number of buyers that are interested to acquire your pharma company in Germany. Corporate Finance in Europe’s team provides M&A services through deep understanding of the value chain of the pharma industry. When selling your German pharma business knowing the market trends and leading international buyers is essential. We guide you in the full process of selling your pharma company. Please get in touch with CFIE to learn more about selling a pharma company in Germany.
We give you advice when selling a pharma company
Is it necessary to know the best practices in the process of selling a pharma business in Germany? CFIE wants to help you in the process of selling your pharma business. This starts with general knowledge about the preparation to sell a company. Next to our pharma industry focus we can offer further services that are required during the process of a business sale. Examples of these services are valuations of pharma companies, due diligence or legal M&A support. Learn more about the process of selling a business at the page sell your business in Europe.
Our M&A advisors in Germany know the pharma and life science markets very well. Here is an overview of the type of pharma activities we come across:
Germany is an important country in the pharmaceuticals industry. Germany is the first country in Europe in regards to clinical trials. There is a lot of pharma companies open for a sale in Germany as the domestic pharmaceutical market in Germany is dominated by small and medium-sized enterprises. Around hundred thousand people work in the pharma industry in Germany. The majority of pharma companies in Germany has less than 100 employees. Only 5 % of all pharmaceutical companies in Germany have more than 500 staff. Germany’s key competitive advantage lies in the combination of low costs for the provided expertise and high quality of staff. A highly trained labour force and a secure legal framework make Germany an interesting country for a sale of a (bio)pharmaceutical company.
Feel free to get in touch for information about selling a pharma business in Germany. Our M&A advisors know the pharma industry in Germany and speak the German language. The advisors of CFIE will help you when selling your pharma company in Germany. We bring you suited international pharma buyers for your business for sale. Please get in touch with CFIE to learn more about how to sell a pharma company in Germany.